NCT04616378

Brief Summary

The purpose of this graduate student research study is to test that a specifically designed and novel robotic prosthetic leg (RPL) is feasible, safe and improves symmetry, efficiency, and metabolic function during sit-to-stand and stand-to-sit transitions as compared to the subject's prescribed device, and as compared to no device at all.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 30, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 5, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

February 1, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2022

Completed
Last Updated

August 29, 2022

Status Verified

August 1, 2022

Enrollment Period

1.2 years

First QC Date

October 30, 2020

Last Update Submit

August 25, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Timed up and go test

    The participant sits in a standard armchair with any assistive device used for walking nearby. The participant stands and at a self-selected walking speed, walks 3 meters, turns, and walks back to the chair, and sits down. A stopwatch records the time to of the test (in seconds).

    two weeks

Secondary Outcomes (1)

  • 10 meter walk test

    one week

Other Outcomes (1)

  • 6 minute walk test

    one week

Study Arms (5)

Phase 2 Prescribed Prosthesis

OTHER

Participants everyday use of prosthesis

Other: Phase 2 Prescribed Prosthesis

Phase 2 Robotic Prosthetic Leg

EXPERIMENTAL

Robotic prosthetic leg with powered knee and passive ankle

Other: Phase 2 Robotic Prosthetic Leg

Phase 3 Prescribed Prosthesis

OTHER

Participants everyday use of prosthesis

Other: Phase 3 Prescribed Prosthesis

Phase 3 Robotic Prosthetic Leg

EXPERIMENTAL

Robotic prosthetic leg with powered knee and passive ankle

Other: Phase 3 Robotic Prosthetic Leg

Phase 3 No Prosthesis

EXPERIMENTAL

Participant performs tasks with no prosthetic device attached

Other: Phase 3 No Prosthesis

Interventions

Everyday used prosthesis that was prescribed by their physician.

Phase 2 Prescribed Prosthesis

The RPL consists of a passive-dynamic ankle, powered knee, and an on-board inertial measurement sensors with an on-board kinetic and kinematic data collection system for analysis.

Phase 2 Robotic Prosthetic Leg

No prosthetic device is attached.

Phase 3 No Prosthesis

The RPL consists of a passive-dynamic ankle, powered knee, and an on-board inertial measurement sensors with an on-board kinetic and kinematic data collection system for analysis.

Phase 3 Robotic Prosthetic Leg

Everyday used prosthesis that was prescribed by their physician.

Phase 3 Prescribed Prosthesis

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • unilateral limb-loss.
  • amputation or knee disarticulation/transfemoral amputation
  • can walk with a variable cadence (Level K3) or play sports (Level K4)
  • uses a prosthesis for walking daily
  • can stand for 30 seconds on one limb
  • can follow one-step commands.

You may not qualify if:

  • Those who can not walk with a variable cadence (Level K1 and K2)
  • compromised skin on the residual limb (stump)
  • uncontrolled swelling
  • missing more than one limb
  • Phase 3
  • unilateral knee disarticulation or transfemoral amputation.
  • can walk at a single speed (Level K2), can walk with a variable cadence (Level K3) or play sports (Level K4)
  • can follow one step commands.
  • Those who do not use prosthesis for walking (Level K1)
  • compromised skin on the residual limb (stump)
  • uncontrolled swelling
  • missing more than one limb

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Loma Linda University

Loma Linda, California, 92354, United States

Location

Study Officials

  • Noha Daher, DrPH

    Loma Linda University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 30, 2020

First Posted

November 5, 2020

Study Start

February 1, 2021

Primary Completion

March 30, 2022

Study Completion

March 30, 2022

Last Updated

August 29, 2022

Record last verified: 2022-08

Locations